Email this page...
send me a copy of the e-mail
Email Off -->
Navigation Speaker Information
Mary Coleman
Senior Director, Investor Relations & Corporate Communications
Savient Pharmaceuticals. Inc.
Mary Coleman is a seasoned investor relations and corporate communications professional with extensive experience in the healthcare industry. As Senior Director of Investor Relations and Corporate Communications for Savient Pharmaceuticals (SVNT), Ms. Coleman manages all aspects of investor relations, public relations and corporate communications. Under her leadership, Savient's Investor Relations program was rated in the top three for all publicly listed mid and micro-companies by the Investor Relations Index for the year ending 2007.

Prior to joining Savient, Ms. Coleman served as Director, Investor and Public Relations at Barrier Therapeutics, Inc. from 2005 to 2007; Director, Corporate Communications at Wolters Kluwer Health, Pharma Solutions from 2003 to 2005; and as Manager, Investor Relations and Corporate Communications at 3-Dimensional Pharmaceuticals, Inc., a Johnson & Johnson Co. from 2002 to 2003.

Ms. Coleman is a Senior Member of National Investor Relations Institute (NIRI), a Public Relations Summit member and a BIO Organization Communication Committee member. She was recognized by Cambridge Who's Who as Outstanding Investor Relations Executive in 2008.

Ms. Coleman's background covers managing high visibility global initiatives in the areas of investor relations, public relations, brand strategy and corporate communications.

 *subject to change


Contact Tammy Dang ( with session inquiries.